Aurinia Pharmaceuticals Shares Down 13% For Session; Co Yesterday Evening Announced In SEC Filing That Co, Lonza Enter Exclusive Agreement For Dedicated Voclosporin Manufacturing Capacity; Says Monoplant Estimated To Be Operational In 2023